Loading...
Microbot Medical Inc.
MBOT•NASDAQ
Healthcare
Medical - Instruments & Supplies
$2.34
$-0.14(-5.65%)
Microbot Medical Inc. (MBOT) Financial Performance & Statements
Review Microbot Medical Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
-17.96%
↓ 17.96%
Net Income Growth
101.69%
↑ 101.69%
Operating Cash Flow Growth
-3.45%
↓ 3.45%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-84.72%
↓ 84.72%
ROIC
-31.87%
↓ 31.87%
Microbot Medical Inc. (MBOT) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Microbot Medical Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $26000.00 | $0.00 | $14000.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | -$14000.00 |
| Gross Profit Ratio | $0.00 | |||
| R&D Expenses | $1.46M | $1.96M | $2.06M | $1.42M |
| SG&A Expenses | $1.56M | $1.37M | $1.24M | $1.09M |
| Operating Expenses | $3.02M | $3.40M | $3.30M | $2.51M |
| Total Costs & Expenses | $0.00 | $3.43M | $3.30M | $2.51M |
| Interest Income | $0.00 | $38000.00 | $0.00 | $46000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $26000.00 | $23000.00 | $14000.00 |
| EBITDA | $0.00 | -$3.40M | -$3.28M | -$2.50M |
| EBITDA Ratio | ||||
| Operating Income | $0.00 | -$3.43M | -$3.30M | -$2.51M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $0.00 | $38000.00 | $85000.00 | $46000.00 |
| Income Before Tax | $104000.00 | -$3.39M | -$3.21M | -$2.46M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $104000.00 | -$3.39M | -$3.21M | -$2.46M |
| Net Income Ratio | ||||
| EPS | -$0.08 | -$0.22 | -$0.20 | -$0.17 |
| Diluted EPS | -$0.08 | -$0.22 | -$0.20 | -$0.17 |
| Weighted Avg Shares Outstanding | $31.09M | $17.02M | $16.47M | $14.85M |
| Weighted Avg Shares Outstanding (Diluted) | $31.09M | $17.02M | $16.47M | $14.85M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan